| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 336,977 | 372,677 | 823,377 | 727,064 | | Cost of Revenue | 186,702 | 210,338 | 473,926 | 445,538 | | | Gross Profit | 150,275 | 162,339 | 349,451 | 281,526 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 145,831 | 136,970 | 156,361 | 159,985 | | Non Recurring | 39,887 |
-
| 4,081 | (43,968) | | Others | 21,111 | 21,040 | 20,894 | 20,743 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (16,667) | 4,329 | 168,115 | 144,766 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 39,887 |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 23,220 | 4,329 | 168,115 | 144,766 | | Interest Expense | 16,639 | 17,181 | 17,795 | 18,725 | | Income Before Tax | 6,581 | (12,852) | 150,320 | 126,041 | | Income Tax Expense | 512 | 670 | 774 | 637 | | Minority Interest | 188 | (3) | (1,711) | (1,441) | | | | Net Income From Continuing Ops | 6,257 | (13,525) | 147,835 | 123,963 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (33,630) | (13,525) | 147,835 | 123,963 | | Preferred Stock And Other Adjustments |
-
|
-
| 1,545 | (1,545) | | | Net Income Applicable To Common Shares | ($33,630) | ($13,525) | $149,380 | $122,418 |
|
0.51% Nasdaq 
Income Statement
